What's Happening?
Representatives Morgan McGarvey (D-Ky.) and Morgan Luttrell (R-Texas) have introduced bipartisan legislation, the Innovation for VA Technology and Entrepreneurship Act (INNOVATE Act), aimed at accelerating the adoption of new medical technologies and treatments
for veterans. The bill would grant the Department of Veterans Affairs (VA) the authority to utilize 'other transaction agreements' and 'advance purchase guarantees,' bypassing traditional contracting methods that often cause significant delays. Under this proposed legislation, a new Office of Innovation would be established within the Veterans Health Administration (VHA), equipped with a dedicated funding account. This office would be authorized to enter into agreements valued up to $10 million each, with larger awards requiring justification to congressional committees. The initiative seeks to reduce the time it takes for innovative medical solutions to reach the over 9 million veterans served by the VA, which currently operates the largest integrated health network in the country. The American Legion, AMVETS, Iraq and Afghanistan Veterans of America, Veterans of Foreign Wars, Vietnam Veterans of America, and Wounded Warrior Project have all endorsed the measure.
Why It's Important?
This legislation is crucial for several reasons, primarily addressing the persistent issue of bureaucratic delays in delivering advanced healthcare to U.S. veterans. The current system often subjects new medical technologies and treatments to lengthy approval processes, hindering timely access for those who have served. By enabling the VA to use 'other transaction agreements' and 'advance purchase guarantees,' the INNOVATE Act aims to streamline procurement, potentially saving lives and improving the quality of life for millions of veterans. This move could also foster greater collaboration between the VA and U.S.-based private sector innovators, encouraging the development of specialized solutions for veteran care. The bill's focus on expanding rural healthcare access and mental and behavioral health services, including suicide prevention, directly targets critical areas of need within the veteran community. Furthermore, the establishment of an Office of Innovation with competitive recruitment capabilities could position the VA as a leader in healthcare innovation, attracting top talent and driving progress in areas where commercial markets may not yet cater specifically to veterans' unique needs. The financial oversight mechanisms, including audits by the VA inspector general and Government Accountability Office, are designed to ensure accountability and prevent misuse of funds.
What's Next?
If passed, the INNOVATE Act would require the VA to implement the changes within 120 days of enactment. The newly established Office of Innovation would be tasked with tracking annual metrics, such as reductions in contracting time, cost savings, and the scaling of pilot programs across the VA system, with results reported to Congress and made publicly available. The bill also mandates that, where practicable, transactions should be open to small businesses, including those owned by veterans and service-disabled veterans. The VA inspector general would audit the innovation account every two years, and the Government Accountability Office would review the 'other transactions' on the same schedule, ensuring continuous oversight. This legislative effort aligns with the VA’s broader December 2025 plan to restructure VHA management to reduce bureaucracy, a process expected to unfold over 18 to 24 months. The bill's progress will likely involve further discussions and potential amendments in Congress, but its bipartisan support suggests a strong likelihood of advancing.
Beyond the Headlines
The INNOVATE Act represents a significant shift in how the VA could acquire and deploy medical technology, moving towards a more agile and responsive model akin to those used by defense and space agencies. This legislative approach acknowledges that traditional government procurement processes are often ill-suited for the rapid pace of technological advancement in healthcare. Beyond the immediate benefits for veterans, this model could serve as a blueprint for other federal agencies grappling with similar bureaucratic hurdles in adopting cutting-edge solutions. The emphasis on U.S.-based participants and the exclusion of foreign adversary ownership or control also highlights a broader national security and economic strategy, aiming to bolster domestic innovation and protect sensitive medical technologies. The bill's potential to allow nonprofit research corporations affiliated with VA medical centers to retain royalties or licensing income from inventions could incentivize groundbreaking research and development directly benefiting veteran health, fostering a more dynamic ecosystem of innovation within the VA.













